Home / Companies / Tscan Therapeutics Inc / Trends
Tscan Therapeutics Inc H-1B trends
Quarterly LCA aggregate trend points for Tscan Therapeutics Inc. Each point carries filing counts, distinct employers, distinct role titles, SOC coverage, wage metrics, certification counts, and source IDs when returned.
Summary
H-1B LCA filings for Tscan Therapeutics Inc span 2020 Q3 to 2026 Q2, peaking at 12 filings in 2026 Q2.
The most recent reported period (2026 Q2) shows 12 filings.
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
| Period | LCA count | Role titles | SOC codes | Avg wage low | Avg prevailing | Certified | Certification rate |
|---|---|---|---|---|---|---|---|
| 2020 Q3 | 2 | 1 | 1 | $127,500 | $103,626 | 1 | 50.0% |
| 2022 Q3 | 2 | 1 | 1 | $84,750 | $84,448 | 2 | 100.0% |
| 2023 Q4 | 3 | 2 | 1 | $87,782 | $87,345 | 2 | 66.7% |
| 2024 Q3 | 4 | 1 | 1 | $75,000 | $74,152 | 3 | 75.0% |
| 2024 Q4 | 1 | 1 | 1 | $92,000 | $91,374 | 1 | 100.0% |
| 2025 Q1 | 4 | 3 | 3 | $117,666 | $112,138 | 4 | 100.0% |
| 2025 Q3 | 3 | 3 | 3 | $101,887 | $101,670 | 3 | 100.0% |
| 2025 Q4 | 2 | 2 | 2 | $225,000 | $191,579 | 2 | 100.0% |
| 2026 Q2 | 12 | 8 | 6 | $106,948 | $104,037 | 12 | 100.0% |
Frequently asked questions
- How have H-1B filings for Tscan Therapeutics Inc changed over time?
- H-1B LCA filings for Tscan Therapeutics Inc span 2020 Q3 to 2026 Q2, peaking at 12 filings in 2026 Q2. The most recent reported period (2026 Q2) shows 12 filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/trends?company=tscan+therapeutics+inc&metric=lca_countJSON